Practical immunology of MS: tailoring our treatments and anticipating their impacts CP 2

Geaccrediteerd voor artsen - 21001890 - 2CP

__FILL_ME_OUT__
Lesduur: 137min
Gepubliceerd:
Accreditatie tot:

Om deze e-learning te volgen, moet u een account hebben en ingelogd zijn.

Geen account? Registreer u hier.

While our armamentarium of so-called high-efficacy drugs grows, each have distinct impacts on the immune system and the underlying disease processes. Mastering these different modes of actions and their consequences is key when choosing for the most adapted treatment strategy and treatment option for an individual patient. The risk of infections and potential for vaccination should also be taken into consideration, especially in the context of the COVID-19 pandemic.

To discuss these key elements, we have here a panel of experts (*) who will complement mechanistic and trial considerations with their own extensive experiences, in order to share useable and practical advices and tips.

(*)
Prof. Luisa Klotz, MD, PhD - Uniklinik Münster, Germany 
Prof. Dr. Bart Van Wijmeersch - Universitair MS Centrum
Prof. Dominique Dive, MD, PhD - University Hospital of Liège, Belgium